Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage

March 19, 2014 updated by: mohammed said elsheemy, Cairo University

Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage in Children With Obstructive Anuria and Acute Renal Failure Due to Ureteral Calculi: a Prospective, Randomized Study

To compare percutaneous nephrostomy (PCN) versus double J stent (JJ) as an initial urinary drainage in children

Study Overview

Detailed Description

To compare percutaneous nephrostomy (PCN) versus double J stent (JJ) as an initial urinary drainage in children with obstructive calcular anuria and acute renal failure due to ureteric calculi to identify selection criteria for initial urinary drainage method to improve drainage, to decrease complications and to facilitate subsequent definitive clearance of stones as this comparison is lacking in literature

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 12222
        • Cairo University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 12 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • children ≤12 years old presenting with Obstructive Anuria and Acute Renal Failure due to bilateral ureteric stones

Exclusion Criteria:

  • Patients with grade 0-1 hydronephrosis
  • fever, pyonephrosis or sepsis.
  • any contraindication to both methods of drainage (urinary diversion, urethral stricture or uncontrolled coagulopathy).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: percutaneous nephrostomy
percutaneous nephrostomy insertion (6-8 Fr in size) for initial urinary drainage followed by definitive stone management.
The 1st arm was drained by PCN. This was performed under general anesthesia (GA) and fluoroscopic guidance.
Other Names:
  • PCN insertion
  • nephrostomy insertion
(shockwave lithotripsy, chemodissolution therapy, ureteroscopy or open surgery) for clearance of stones.
Other Names:
  • DSM
Active Comparator: Bilateral double J ureteric stents
double J ureteric stent insertion (4.8-6 Fr JJ in size) for initial urinary drainage followed by definitive stone management.
(shockwave lithotripsy, chemodissolution therapy, ureteroscopy or open surgery) for clearance of stones.
Other Names:
  • DSM
The 2nd arm was drained by bilateral JJ . This was performed under general anesthesia (GA) and fluoroscopic guidance.
Other Names:
  • JJ

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Period to Return to Normal Creatinine
Time Frame: 1 week

period required for normalization of serum creatinine after initial urinary drainage using percutaneous nephrostomy or ureteric stent in children with obstructive calcular anuria and Acute Renal Failure

serum creatinine was compared to normal values in matched healthy children

1 week
Complications of Each Drainage Method
Time Frame: 1 week

complications of initial urinary drainage using percutaneous nephrostomy or ureteric stent in children with Obstructive Anuria and Acute Renal Failure (mucosal complications, failure of insertion, slippage, fever and infection, hematuria, leakage)

complications were calculated per 45 ureterorenal units in PCN group and 90 ureterorenal units in Double J group

1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Number of Subsequent Interventions Needed for Clearance of Stones .
Time Frame: 6 months
The number of subsequent interventions needed for clearance of stones after normalization of serum creatinine in relation to initial urinary drainage method using percutaneous nephrostomy or ureteric stent in children with Obstructive Anuria and Acute Renal Failure
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Factors Affecting the Outcome of Each Group (Operative Time, Safety and Efficacy)
Time Frame: 1 week

age, site of stones, size of stones, degree of hydronephrosis

they were calculated per 45 ureterorenal units in PCN group and 90 ureterorenal units in Double J group

1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2010

Primary Completion (Actual)

March 1, 2013

Study Completion (Actual)

September 1, 2013

Study Registration Dates

First Submitted

February 3, 2014

First Submitted That Met QC Criteria

February 3, 2014

First Posted (Estimate)

February 5, 2014

Study Record Updates

Last Update Posted (Estimate)

April 23, 2014

Last Update Submitted That Met QC Criteria

March 19, 2014

Last Verified

March 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children

Clinical Trials on percutaneous nephrostomy insertion

3
Subscribe